SYNOPSIS Sera from 5171 inpatients have been tested for HBAg and HBAb during the 18-month period ending in December 1972. The incidence of HBAg (0-116%) was similar to that in blood donors (0-119%) in the same area, being tested for the first time by the same technique. By contrast the incidence of HBAb in patients (0*271 %) was significantly higher than in donors (0-103 %). A possible mode of infection was identified in three of six HBAg-positive patients and in seven of 12 HBAb patients. None of the positive patients was regarded as 'high risk' when admitted to hospital. The study thus emphasizes the need to regard all specimens as potentially infective.
The hepatitis-associated antigen (HAA), formerly known as Australia antigen, appears to be a specific marker for 'serum' or viral hepatitis type B (Blumberg, Sutnick, and London, 1968; Prince, 1968) . A recent World Health Organization report (1973) proposes that HAA or Australia antigen should be referred to as hepatitis B antigen (HBAg) and the corresponding antibody as hepatitis B antibody (HBAb) . Although this antigen may not itself be the actual infective agent, any individuals found to be HBAg positive must be regarded as potentially infectious. There is little published information regarding the prevalence of HBAg in hospital patients, and indeed most of the available figures refer to prevalence rates in healthy blood donors. There is, however, no reason to suppose that patients referred to hospital are in this respect atypical and hospitals must constantly be treating unknown carriers of HBAg (Department of Health and Social Security, 1972a) .
This study was primarily undertaken to determine the prevalence of HBAg and HBAb among selected inpatients in a general hospital group and among healthy blood donors in the same region over the same period of time; and secondarily to investigate implications of the findings.
Materials and Methods

PATIENTS
An aliquot of serum was obtained from each inpatient in whom blood grouping was performed in the Haematology Department of the Victoria Received for publication 9 November 1973.
Infirmary. The serum samples were stored at -20°C and subsequently transferred at weekly intervals to the Glasgow and West of Scotland Regional Trans fusion Centre for HBAg and HBAb testing. Sera from 5171 individual patients were tested between June 1971 and December 1972. These 5171 patients represented 29 % of the patients admitted to hospital during the same period of time: 83 % were admitted to surgical and 17% to medical wards.
A detailed medical history was obtained from those patients in whom HBAg or HBAb was de tected; in addition biochemical tests of liver function were performed.
BLOOD DONORS
Since October 1970, the sera of all blood donors in the west of Scotland have been routinely tested for the presence of HBAg and HBAb; 86 182 donors were tested for the first time between June 1971 and December 1972.
HBAg positive (0-116%), while 103 out of a total of 86 182 blood donors were HBAg positive (0*119%) (table I). The difference is not statistically significant. , 1972b) .
Possible modes of infection
The six HBAg patients and 12 of the 14 HBAb R. W. Payne, A. Barr, and J. Wallace patients were closely questioned concerning their previous medical history; in two HBAb patients this was not practicable. Particular attention was paid to a history of previous transfusion of blood or blood products; of jaundice occurring within six months of transfusion; of jaundice or hepatitis of unknown type or close contact with a jaundiced individual within the previous six months; of any injection within the previous six months and of previous pulmonary tuberculosis treated with chemotherapy. These findings are summarized in tabic 111. A history of blood transfusion before the screening of donations for HBAg was obtained from one of six HBAg patients and from six of 12 HBAb patients; two of those HBAb patients had developed jaundice within six months of transfusion. None of the HBAg patients admitted to any episode of jaundice, but one admitted to close contact with a jaundiced individual during the previous six months. One of the HBAb patients admitted to an episode of jaun dice some 30 years earlier, while, as noted above, two other patients had in the past had posttransfusion jaundice. Histories of injection within the previous six months were obtained from one HBAg patient and three HBAb patients. One HBAg patient and three HBAb patients gave histories of pulmonary tuberculosis treated with chemotherapy during the previous 10 years. Thus, in summary, a possible mode of infection was identified in three of six HBAg patients and in seven of 12 HBAb patients. 
Discussion
The hepatitis B antigen (HBAg) appears to be a specific marker for the viraemic phase of so-called 'serum* hepatitis (Blumberg et al, 1968; Prince, 1968) , although there is no direct evidence that it is the infectious agent of the disease (Taylor, 1972) . The significance of the corresponding antibody (HBAb) is less certain, but it probably represents evidence of earlier infection (Department of Health and Social Security, 1972a). Heathcote and Sherlock (1973) studied the spread of acute viral hepatitis type B, and found that non-parenteral spread was more common than parenteral. Close contact with HBAg carriers now appears to be the single most important factor in the spread of type B hepatitis in a large, urban, cosmopolitan community. Reports of the prevalence of HBAg and HBAb among healthy blood donors have been sum marized (Maycock, 1972) . The prevalence of the antigen appears to be higher in paid than in unpaid donors and also to show considerable geographical variation, the lowest rates quoted being in the United Kingdom (0 07% in Sheffield) and the highest in Kenya (6-0%). Less information regarding the prevalence of the antibody is available; a rate of 0 03% in Sheffield can be compared with a rate of 0 4% in France.
Little information is available regarding the pre valence of HBAg in general hospital patients. Cossart has reviewed the prevalence of HBAg in various groups of patients at special risk (Cossart, 1972) , and a prevalence rate of 0-34% for hospital admissions in Denmark has been reported (Cherubin and Prince, 1971 ). An overall prevalence rate of 1-34% for HBAg has recently been repui led in patients attending a venerea! disease clinic in London (Jeffries, James, Jefferiss, MacLeod, and Willcox, 1973) . JFulford, Dane, Catterall, Woof, and Denning (1973) also found a high frequency of HBAg and of HBAb in patients attending a clinic for sexually transmitted diseases. In both these studies it was shown that there were distinct popula tions, the highest rates of exposure to type B hepa titis virus being found in homosexual patients. Heathcote and Sherlock (1973) have also empha sized the importance of close sexual contact in the transmission of type B hepatitis.
Many different methods of testing for HBAg and HBAb have been described, and these vary considerably in their sensitivity (Department of Health and Social Security, 1972b; Taylor, 1972) . It is therefore quite possible that some of the differ ences in reported prevalence are due to variations in the sensitivity of methods of testing used. The World Health Organization Report (1973) states that the successful detection of HBAg and HBAb depends as much on the meticulous performance of the chosen test as on its relative sensitivity. For these reasons comparison and interpretation of reported prevalence in different studies require considerable caution. In the present study both hospital patients and blood donors were iested in one centre using the same technique (IEOP). Bloofield (1973) has challenged the validity of using blood donors in comparative studies, because in some countries potential donors with, a history of jaundice or of contact in the past six months with a case of jaundice are rejected. Cossart (1972) also considers that the exclusion of volunteers with a past history of jaundice makes a population of blood donors unrepresentative of the community as a whole. The World Health Organiza tion (1973) , however, suggests that individuals with a history of overt hepatitis may not have a high inci dence of HBAg, and evidence supporting this con tention has recently appeared (Wallace, 1973) .
Clearly, however, both hospital inpatients and blood donors form highly selected groups of the general population, and within these groups of patients and of donors there are subpopulations according to age, sex, race, and social class. The patients studied showed considerable 'surgical' bias and formed a further selected group within the general hospital population. It is interesting never theless that the prevalence of HBAg was found to be very similar in both the patients and donors (0*12%), whereas the prevalence of HBAb was considerably greater in the patients (0-27%) than in the donors (010%). That this difference is due to the exclusionof some potential blood donors because R. W. Payne, A. Barr, and J. Wallace of their previous medical history seems unlikely (Wallace, J973) .
Potential modes of infection were identified in just over half the HBAg or HBAb hospital patients. Conversely and perhaps more importantly no such episode was identified in nearly half of these patients. These findings not only confirm the importance of blood donations unscreened for HBAg and the parenteral route of infection, but also lend support to the suggestion of a natural circulation of the virus in the community (Cossart, 1972) . In their study of the spread of acute typz B hepatitis, Heath cote and Sherlock (1973) found no definite source of infection in 24 out of 67 patients.
Although the possibility of subclinical hepatitis cannot be absolutely excluded, it seems more likely that the HBAg-positive hospital patients were 'healthy carriers' of the virus, since biochemical liver function tests were all normal. Similarly liver function tests were also normal in the HBAbpositive patients, in whom this finding was probably evidence of earlier infection. Hospitals must con stantly be treating unknown carriers of HBAg.
The risks of handling specimens of unfixed tissues, blood, and body fluids from 'high-risk' patients have been emphasized recently (Department of Health and Social Security, 1972c) . None of the patients in this study subsequently found to be HBAg or HBAb positive was regarded as a 'high-risk" patient when admitted to hospital. However, one in 862 (0-12%) specimens submitted for routine blood grouping was found to contain HBAg in retrospect; in addition specimens had been ex amined in other laboratories for routine diagnostic purposes before this information became avail able. This study again emphasizes the importance of regarding all specimens as highly infective and. of handling all specimens with great care.
